Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin versus placebo during insulin withdrawal in type 1 and type 3c diabetes
ISRCTN16404006Phase 4Completed
- Sponsor
- University of Leicester
- Start
- Jan 2018
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of dapagliflozin in diabetes mellitus type 1 (T1D) and pancreatogenic diabetes mellitus (T3cDM) (2 arms), sponsored by University of Leicester. Started Jan 2018; status: completed.
02
Drugs
dapagliflozin
03
Conditions
diabetes mellitus type 1 (T1D)pancreatogenic diabetes mellitus (T3cDM)
Beyond the preview
Go deeper on ISRCTN16404006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16404006.